Skip to main content
. Author manuscript; available in PMC: 2017 Oct 3.
Published in final edited form as: Curr Drug Targets. 2017;18(7):826–843. doi: 10.2174/1389450116666150825110532

Figure 4.

Figure 4

Humoral immune responses in acute resolving (A) and chronic (B) HCV infection. A) Rapid development of HCV-specific nAb may contribute to spontaneous resolution of infection. Ab to HCV structural and non-structural proteins can be detected by enzyme-linked immunoassay (EIA). Ab levels may decline after infection is cleared. B) Slower development of nAb responses may predispose to chronic infection. Ab to structural and non-structural proteins is detectable by EIA.